Literature DB >> 21952983

Comparison of the effects of genetic and environmental risk factors on in situ and invasive ductal breast cancer.

Gillian K Reeves1, Kirstin Pirie, Jane Green, Diana Bull, Valerie Beral.   

Abstract

Little is known about the etiology of in situ ductal breast cancer (DCIS) or what influences its possible progression to invasive ductal disease. Comparison of risk factors for DCIS and invasive ductal cancer may throw some light on these issues. We estimated relative risks for DCIS and invasive ductal breast cancer according to 12 genetic and eight environmental risk factors among 1.1 million postmenopausal women in a large prospective UK study. There was no strong evidence of a different association with DCIS versus invasive ductal cancer for any of the 12 susceptibility loci examined. We also found similar associations of age at menarche, age at first birth, parity, age at menopause, family history of breast cancer and use of hormone replacement therapy with DCIS and invasive ductal cancer. Only body mass index (BMI) showed a clear difference in association in that it was positively associated with the risk of invasive ductal cancer but not DCIS (RRs per 5 kg/m(2) = 1.20 and 1.01, respectively; p-value for heterogeneity = 0.002). The very similar risk factor profiles observed here for DCIS and invasive ductal cancer suggest that DCIS is a precursor of invasive ductal cancer and most risk factors affect the risk of invasive ductal cancer primarily through their effects on the risk of DCIS. The lack of association between BMI and DCIS suggests a greater influence of BMI on disease progression.
Copyright © 2011 UICC.

Entities:  

Mesh:

Year:  2011        PMID: 21952983     DOI: 10.1002/ijc.26460

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  31 in total

1.  Epidemiologic Risk Factors for In Situ and Invasive Breast Cancers Among Postmenopausal Women in the National Institutes of Health-AARP Diet and Health Study.

Authors:  Maeve Mullooly; Zeina G Khodr; Cher M Dallal; Sarah J Nyante; Mark E Sherman; Roni Falk; Linda M Liao; Jeffrey Love; Louise A Brinton; Gretchen L Gierach
Journal:  Am J Epidemiol       Date:  2017-12-15       Impact factor: 4.897

Review 2.  The benefits and harms of breast cancer screening: an independent review.

Authors:  M G Marmot; D G Altman; D A Cameron; J A Dewar; S G Thompson; M Wilcox
Journal:  Br J Cancer       Date:  2013-06-06       Impact factor: 7.640

3.  Combined associations of genetic and environmental risk factors: implications for prevention of breast cancer.

Authors:  Montserrat Garcia-Closas; Necdet Burak Gunsoy; Nilanjan Chatterjee
Journal:  J Natl Cancer Inst       Date:  2014-11-12       Impact factor: 13.506

4.  Neoadjuvant chemotherapy of breast cancer with pirarubicin versus epirubicin in combination with cyclophosphamide and docetaxel.

Authors:  Xi Gu; Shi Jia; Wei Wei; Wen-Hai Zhang
Journal:  Tumour Biol       Date:  2015-02-15

5.  Galectin-3 rs4652 A>C polymorphism is associated with the risk of gastric carcinoma and P-glycoprotein expression level.

Authors:  Yi Shi; Xiandong Lin; Gang Chen; Jun Yan; Mingang Ying; Xiongwei Zheng
Journal:  Oncol Lett       Date:  2017-10-23       Impact factor: 2.967

Review 6.  Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention.

Authors:  Nicole M Davis; Melissa Sokolosky; Kristin Stadelman; Steve L Abrams; Massimo Libra; Saverio Candido; Ferdinando Nicoletti; Jerry Polesel; Roberta Maestro; Antonino D'Assoro; Lyudmyla Drobot; Dariusz Rakus; Agnieszka Gizak; Piotr Laidler; Joanna Dulińska-Litewka; Joerg Basecke; Sanja Mijatovic; Danijela Maksimovic-Ivanic; Giuseppe Montalto; Melchiorre Cervello; Timothy L Fitzgerald; Zoya Demidenko; Alberto M Martelli; Lucio Cocco; Linda S Steelman; James A McCubrey
Journal:  Oncotarget       Date:  2014-07-15

7.  Risk factors for young-onset invasive and in situ breast cancer.

Authors:  Katie M O'Brien; Jenny Sun; Dale P Sandler; Lisa A DeRoo; Clarice R Weinberg
Journal:  Cancer Causes Control       Date:  2015-09-25       Impact factor: 2.506

8.  Sodium citrate inhibits the proliferation of human gastric adenocarcinoma epithelia cells.

Authors:  Yuan Xia; Xulong Zhang; Agula Bo; Juan Sun; Minhui Li
Journal:  Oncol Lett       Date:  2018-02-23       Impact factor: 2.967

9.  Opportunities for molecular epidemiological research on ductal carcinoma in-situ and breast carcinogenesis: interdisciplinary approaches.

Authors:  Mark E Sherman; Carolyn Mies; Gretchen L Gierach
Journal:  Breast Dis       Date:  2014

10.  Population-Attributable Risk Proportion of Clinical Risk Factors for Breast Cancer.

Authors:  Natalie J Engmann; Marzieh K Golmakani; Diana L Miglioretti; Brian L Sprague; Karla Kerlikowske
Journal:  JAMA Oncol       Date:  2017-09-01       Impact factor: 31.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.